Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

AMXOL TABLETS 30 mg - HSA Drug Approval Details

Approvals/HSA/AMXOL TABLETS 30 mg

Approved

THERAPEUTIC

AMXOL TABLETS 30 mg

BIOLAB CO LTD🇸🇬 Health Sciences Authority

Approval Date: May 20, 1989
Approval ID: dcf33113cbdf6cf4
Company: BIOLAB CO LTD
Type: Therapeutic

Approval Details

Approval Id: dcf33113cbdf6cf4
Drug Name: AMXOL TABLETS 30 mg
Product Name: AMXOL TABLETS 30 mg
Approval Number: SIN02983P
Approval Date: 1989-05-20
Registrant: MEDISPEC RENAISSANCE PTE. LTD.
Licence Holder: MEDISPEC RENAISSANCE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: R05CB06
Atc Item Name: ambroxol
Pharma Manufacturer Name: MEDISPEC RENAISSANCE PTE. LTD.
Company Detail Path: /organization/medispec-renaissance-pte-ltd

Active Ingredients

Ambroxol HCl

30 mg

Ambroxol HCl

30 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

May 20, 1989

Approval ID

dcf33113cbdf6cf4

Type

Therapeutic

Back to HSA Approvals